You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 147 No. 9, September 1987 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Serum Protein Electrophoresis Patterns in Chronic Lymphocytic Leukemia

Clinical and Epidemiologic Correlations

Robin H. Miller, MD, MHS; Martha S. Linet, MD, MPH; Mark L. Van Natta; Lee D. McCaffrey, MA; Richard L. Humphrey, MD

Arch Intern Med. 1987;147(9):1614-1617.


Abstract



• Serum protein electrophoresis (SPEP) data obtained at diagnosis were available for 98 of 342 patients with chronic lymphocytic leukemia (CLL) identified in a population-based case-control epidemiologic study. Patients tested with SPEP at diagnosis were significantly younger, more likely to have lymphadenopathy, and more likely to have had their conditions diagnosed at a university hospital than those not tested. Four categories of electrophoretic patterns were identified: normal (N=56), hypogammaglobulinemia (N=28), hypergammaglobulinemia (N=11), and monoclonal gammopathy (N=3). A higher proportion of those with hypergammaglobulinemia were black, and patients with hypergammaglobulinemia and monoclonal gammopathy were more likely to die within the first year following diagnosis than patients in the other SPEP groups. No association was found, however, between SPEP pattern and a clinical staging classification for CLL. These findings suggest that SPEP may be a useful adjunct in categorizing possible subtypes of CLL and developing future clinical staging classifications.

(Arch Intern Med 1987;147:1614-1617)



Author Affiliations



From the Division of Internal Medicine, Stony Brook (NY) School of Medicine (Dr Miller); the Department of Epidemiology, Johns Hopkins School of Hygiene and Public Health (Dr Linet, Mr Van Natta, and Ms McCaffrey), and Johns Hopkins Oncology Center (Dr Humphrey), Baltimore.


Footnotes



Accepted for publication June 22, 1987.

Read in part before the national meeting of the American Association of Cancer Research, Los Angeles, May 7, 1986.

Reprint requests to Division of Internal Medicine, T-16, Room 080, SUNY-Stony Brook, HSC, Stony Brook, NY 11794 (Dr Miller).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.